There are 29 resources available
Participants clinical case discussion: Metastatic hormone-sensitive prostate cancer (mHSPC) in 43 year-old patient – how to treat in case of progression after triplet therapy?
Presenter: T. Rosan, HR
Session: Session 4 - Castration-sensitive metastatic prostate cancer
Resources:
Slides
Webcast
Non metastatic CRPC: Current treatment
Presenter: G. Baciarello, IT
Session: Session 5 - Non metastatic and metastatic castration-resistant disease
Resources:
Slides
Webcast
Metastatic CRPC: Current treatment
Presenter: S. Gillessen, CH
Session: Session 5 - Non metastatic and metastatic castration-resistant disease
Resources:
Slides
Webcast
PSMA-based therapies
Presenter: K. Herrmann, DE
Session: Session 5 - Non metastatic and metastatic castration-resistant disease
Resources:
Slides
Webcast
Participants clinical case discussion: Prostate cancer treatment
Presenter: A. Tymoshenko, UA
Session: Session 5 - Non metastatic and metastatic castration-resistant disease
Resources:
Slides
Webcast
Participants clinical case discussion: A case of cardiac disfunction worsening with androgen deprivation therapy + androgen receptor pathway inhibitor in metastatic hormone-sensitive de novo prostate cancer
Presenter: M. Rosellini, IT
Session: Session 5 - Non metastatic and metastatic castration-resistant disease
Resources:
Slides
Webcast
Treatment in frail patients with mCRPC
Presenter: E. Castro, ES
Session: Session 6 - Metastatic castration-resistant disease
Resources:
Slides
Webcast
Experimental treatments for mCRPC
Presenter: K. Fizazi, FR
Session: Session 6 - Metastatic castration-resistant disease
Resources:
Slides
Webcast
Participants clinical case discussion: Neuroendocrine differentiation of prostate adenocarcinoma with BRCA2 mutation
Presenter: M. Garcia de Herreros, ES
Session: Session 6 - Metastatic castration-resistant disease
Resources:
Slides
Webcast